On the upside
AspenBio Pharm (Nasdaq: APPY) moved its coference call from Thursday January 22 to Wednesday January 21 at 9am Eastern time to discuss preliminary results from a clinical trial of its blood-based test to diagnose appendicitis.
Robert W. Baird analyst Peter Lisnic upgraded Woodward Governor (Nasdaq: WGOV) citing the company's upbeat first quarter earnings.
Northern Trust (Nasdaq: NTRS) reported sharply higher first quarter earnings that more than doubled.
On the downside
Omnicell (Nasdaq: OMCL) disappointed with its 2009 outlook that was less than half of expectations prompting a downgrade.
UAL (Nasdaq: UAUA), parent company of United Airlines, significantly widened first quarter losses and announced the elimination of another 1,000 positions.
Coach (NYSE: COH) blamed disappointing holiday sales for lower second quarter earnings.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by nearly 8 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 7 points to 441.
